In This Article:
CALGARY, Alberta - (NewMediaWire) - August 29, 2024 - Ocumetics Technology Corp. ("Ocumetics") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a pioneer in vision enhancement technology, is pleased to announce the successful fabrication of an intraocular lens (IOL) that is designed to respond to muscle activity that controls the curvature of the natural lens in the human eye. This achievement puts Ocumetics one step closer to the first human implantation scheduled to occur in early 2025.
Accommodation is the ability to change the focus of the eye from distance to near. Accommodation is based on the ability of the natural lens of the eye to change its shape in response to forces exerted by the ciliary muscles, which surround the natural lens of the eye.
The Ocumetics accommodating IOL is designed to respond to these same natural forces by changing its shape in a way that changes its curvature and ultimately, its focus from near objects to objects in the distance. Using a precise measuring device called the IOLA, physiologic compression forces like the ones in the human eye were found to change the focal point of the Ocumetics lens from distance to a point a few inches away, which is similar to the ability of a 10-year-old person to accommodate.
"The results of this laboratory experiment validate the design of the Ocumetics accommodating IOL that has been theoretical, up until this point," commented Dr. Garth Webb, Chief Scientist at Ocumetics, who has been working on design details of this lens for more than a decade.
"We believe this achievement will catapult Ocumetics to the forefront of accommodating lens design," said Dean Burns, CEO of Ocumetics. "It is extremely satisfying to witness Dr. Webb's aspiration become a reality."
Demonstration of accommodation in response to forces believed to be generated in the human eye is an essential step toward finalization of lens design for the upcoming first-in-human lens implantations, scheduled for early next year.
For more information about Ocumetics Technology Corp. and our cutting-edge vision enhancement solutions, please visit Ocumetics.com.
About Ocumetics
Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is a Canadian research and product development company that is dedicated to developing advanced vision correction solutions that enhance the quality of life for patients. Through innovative research and development, Ocumetics aims to transform the field of ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies.